In Vitro Evaluation of ALDH1A3-Affinic Compounds on Breast and Prostate Cancer Cell Lines as Single Treatments and in Combination with Doxorubicin
Aldehyde dehydrogenase (ALDH) enzymes are involved in the growth and development of several tissues, including cancer cells. It has been reported that targeting the ALDH family, including the ALDH1A subfamily, enhances cancer treatment outcomes. Therefore, we aimed to investigate the cytotoxicity of...
Main Authors: | Osama H. Abusara, Ali I. M. Ibrahim, Hamzah Issa, Alaa M. Hammad, Worood H. Ismail |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/45/3/139 |
Similar Items
-
Doxorubicin-enriched, ALDH<sup>br</sup> mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1
by: Zhuang Xiufen, et al.
Published: (2012-11-01) -
Combination prostate cancer therapy: Prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone
by: Guanxing Sun, et al.
Published: (2021-01-01) -
Silybin Prevents Prostate Cancer by Inhibited the ALDH1A1 Expression in the Retinol Metabolism Pathway
by: Ying Jiang, et al.
Published: (2020-08-01) -
PCL-based nanoparticles for doxorubicin-ezetimibe co-delivery: A combination therapy for prostate cancer using a drug repurposing strategy
by: Mina Yousefnezhad, et al.
Published: (2023-05-01) -
The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment
by: Hong Zhang, et al.
Published: (2021-06-01)